Cargando…

Russian Registry of Idiopathic Pulmonary Fibrosis: Clinical Features, Treatment Management, and Outcomes

SIMPLE SUMMARY: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease of unknown etiology characterized by the rapid development of respiratory failure and a poor outcome. No effective treatment is available worldwide to stop the progression of this disease and to recover the fib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chikina, Svetlana, Cherniak, Alexander, Merzhoeva, Zamira, Tyurin, Igor, Trushenko, Natalia, Proshkina, Anna, Ataman, Kirill, Avdeev, Sergey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964580/ https://www.ncbi.nlm.nih.gov/pubmed/36836792 http://dx.doi.org/10.3390/life13020435

Ejemplares similares

Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Predictors of Progression and Mortality in Patients with Chronic Hypersensitivity Pneumonitis: Retrospective Analysis of Registry of Fibrosing Interstitial Lung Diseases
por: Trushenko, Natalia V., et al.
Publicado: (2023)

How can we predict the failure of awake proning in acute hypoxemic respiratory failure associated with COVID-19?
por: Avdeev, Sergey N., et al.
Publicado: (2022)

Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Predictors of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients with Hypersensitivity Pneumonitis
por: Trushenko, Natalia V., et al.
Publicado: (2023)

Pain, Swelling and Blue Discoloration of Right Hand in a COVID-19 Patient
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale
por: Kosanovic, Djuro, et al.
Publicado: (2021)

Breathing pattern, accessory respiratory muscles work, and gas exchange evaluation for prediction of NIV failure in moderate-to-severe COVID-19-associated ARDS after deterioration of respiratory failure outside ICU: the COVID-NIV observational study
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022)

Using TAPSE (tricuspid annular plane systolic excursion) as a predictor of poor prognosis of COVID-19: is it enough?
por: Nekludova, Galina V., et al.
Publicado: (2021)

Effects of Pirfenidone on Idiopathic Pulmonary Fibrosis Progression and Safety: Results of Multicenter Prospective Observational Study
por: Avdeev, Sergey, et al.
Publicado: (2023)

N-acetylcysteine for the treatment of COVID-19 among hospitalized patients
por: Avdeev, Sergey N., et al.
Publicado: (2022)

Lung ultrasound presentation of covid-19 patients: phenotypes and correlations—comment
por: Nekludova, Galina, et al.
Publicado: (2021)

Potential for the lung recruitment and the risk of lung overdistension during 21 days of mechanical ventilation in patients with COVID-19 after noninvasive ventilation failure: the COVID-VENT observational trial
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022)

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment
por: Aisanov, Zaurbek, et al.
Publicado: (2018)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
por: Nashatyreva, Maria S., et al.
Publicado: (2023)

Patient Registries in Idiopathic Pulmonary Fibrosis
por: Culver, Daniel A., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China
por: Richeldi, Luca, et al.
Publicado: (2015)

Correction to: Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China
por: Richeldi, Luca, et al.
Publicado: (2021)

The Russian Registry of Chronic Hypoparathyroidism
por: Kovaleva, Elena V., et al.
Publicado: (2022)

Can lung ultrasound predict histologic pattern of lung injury in critically ill patients with COVID‑19?
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Lung ultrasound can predict response to the prone position in awake non-intubated patients with COVID‑19 associated acute respiratory distress syndrome
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome
por: Tsareva, Natalia A., et al.
Publicado: (2021)

Asthma in older adults with severe coronavirus disease 2019: Clinical outcomes and predictors of mortality
por: Avdeev, Sergey N., et al.
Publicado: (2022)

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
por: Snyder, Laurie D, et al.
Publicado: (2020)

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry
por: Chazova, Irina Yev., et al.
Publicado: (2020)

The Russian registry of primary hyperparathyroidism, latest update
por: Mokrysheva, Natalia G., et al.
Publicado: (2023)

Antimicrobial Prescribing Patterns in Patients with COVID-19 in Russian Multi-Field Hospitals in 2021: Results of the Global-PPS Project
por: Avdeev, Sergey, et al.
Publicado: (2022)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

Patient Registries in Idiopathic Pulmonary Fibrosis: Don't Forget Socioeconomic Status
por: Sesé, Lucile, et al.
Publicado: (2020)

The world is not enough – the value of increasing registry data in idiopathic pulmonary fibrosis
por: Moor, C. C., et al.
Publicado: (2020)

Vertical program of screenings and check-ups in the Russian Federation: design, implementation and lessons learnt
por: Sheiman, Igor, et al.
Publicado: (2022)

Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
por: Jegal, Yangjin, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study
por: Xie, Bingbing, et al.
Publicado: (2020)

SABA Overuse in Russia – Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study
por: Avdeev, Sergey, et al.
Publicado: (2022)

Cystic Fibrosis Polymorphic Variants in a Russian Population
por: Kiseleva, Anna, et al.
Publicado: (2020)

Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
por: O'Brien, Emily C, et al.
Publicado: (2016)

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
por: Behr, Jürgen, et al.
Publicado: (2015)

Collecting Occupational Exposure Data Would Strengthen Idiopathic Pulmonary Fibrosis Registries
por: Nett, Randall J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_se2rs9efhhdk39hl0pt6shkuie